Toll Free: 1-888-928-9744

Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Portola Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Portola Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Portola Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Portola Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Portola Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

- Evaluate Portola Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Portola Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Portola Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Portola Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Portola Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Portola Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Portola Pharmaceuticals, Inc. Snapshot 5
Portola Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Portola Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Portola Pharmaceuticals, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Portola Pharmaceuticals, Inc. - Pipeline Products Glance 11
Portola Pharmaceuticals, Inc. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Portola Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Portola Pharmaceuticals, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Portola Pharmaceuticals, Inc. - Unknown Stage Pipeline Products 15
Unknown Products/Combination Treatment Modalities 15
Portola Pharmaceuticals, Inc. - Drug Profiles 16
betrixaban 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PRT-4445 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PRT-2070 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PRT-2607 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PRT-060318 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PRT-061103 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Portola Pharmaceuticals, Inc. - Pipeline Analysis 23
Portola Pharmaceuticals, Inc. - Pipeline Products by Target 23
Portola Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 24
Portola Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 25
Portola Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 26
Portola Pharmaceuticals, Inc. - Recent Pipeline Updates 27
Portola Pharmaceuticals, Inc. - Dormant Projects 34
Portola Pharmaceuticals, Inc. - Discontinued Pipeline Products 35
Discontinued Pipeline Product Profiles 35
betrixaban 35
elinogrel potassium 35
PRT-2607 35
Portola Pharmaceuticals, Inc. - Locations And Subsidiaries 36
Head Office 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38
List of Tables
Portola Pharmaceuticals, Inc., Key Information 5
Portola Pharmaceuticals, Inc., Key Facts 5
Portola Pharmaceuticals, Inc. - Pipeline by Indication, 2014 8
Portola Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9
Portola Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10
Portola Pharmaceuticals, Inc. - Phase III, 2014 11
Portola Pharmaceuticals, Inc. - Phase II, 2014 12
Portola Pharmaceuticals, Inc. - Phase I, 2014 13
Portola Pharmaceuticals, Inc. - Preclinical, 2014 14
Portola Pharmaceuticals, Inc. - Unknown, 2014 15
Portola Pharmaceuticals, Inc. - Pipeline by Target, 2014 23
Portola Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 24
Portola Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 25
Portola Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 26
Portola Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 27
Portola Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 34
Portola Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 35 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify